These included: BRCA2 p.Trp1692fs (P) associated with hereditary breast and ovarian cancer, MSH2 p.Leu341Val (LP) associated with Lynch syndrome, and the novel PTEN p.Ile50Ter (LP) associated with Cowden syndrome and glioma susceptibility. This evidence concerns the gene MSH2 and central nervous system cancer.